OR4C9P

Across TCGA pan-cancer cohorts, OR4C9P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR4C9P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher OR4C9P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4C9P expression acts as an unfavorable survival marker.

OV, KIRC, and PAAD are the cancer types where OR4C9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.316	0.544	.024	54	view →
KIRC	OS	Tertile	All	0.634	0.810	.010	42	view →
PAAD	DFS	Tertile	All	0.118	0.468	.012	27	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
SARC	OS	Tertile	All	0.085	0.827	<.001	18	view →
GBM	OS	Tertile	All	0.099	0.413	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR4C9P–OV (DFS)

Open the OV breakdown →